title: Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.
authors.affiliation: University of Bristol and Bristol Children's Hospital, Bristol, UK. nick.goulden@bristol.ac.uk
authors.forename: N
authors.initials: N
authors.lastname: Goulden
authors.forename: A
authors.initials: A
authors.lastname: Oakhill
authors.forename: C
authors.initials: C
authors.lastname: Steward
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D016026:Bone Marrow Transplantation; D002648:Child; D003365:Costs and Cost Analysis; D006801:Humans; D018365:Neoplasm, Residual / Q000473:pathology*; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents